Medical Diagnostics Equipment With Proprietary Technologies For Approach Towards HIV Applications
-
Manufactured by Gritstone Biobased in USA
The first pillar of our immunotherapy is our understanding of antigens and neoantigens, and specifically which ones will be transcribed, translated, processed and presented on a cell surface by Human leukocyte antigen (HLA) molecules; and therefore will be visible to T cells. We accomplish this through the use of Gritstone EDGETM, our proprietary machine learning-based ...
-
Manufactured by Gritstone Biobased in USA
We have a collaboration established with Gilead Sciences to research and develop a vaccine-based immunotherapy as part of Gilead’s efforts to cure patients with human immunodeficiency virus (HIV) infection. The companies are developing an HIV-specific therapeutic vaccine using Gritstone’s proprietary prime-boost vaccine platform, comprised of self-amplifying mRNA (samRNA) and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you